Suppression of the degradation of adenine nucleotides during ischemia may not be a sufficient mechanism for infarct size limitation by preconditioning

Basic Research in Cardiology

Volumn 91, Issue 6, 1996, Pages 425-432

  Miura, T ^a   Suzuki, K ^a   Shimamoto, K ^a   Iimura, O ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenosine; Bradykinin; Microdialysis; Myocardial infarction; Rabbit

Indexed keywords

8 PHENYLTHEOPHYLLINE; ADENINE NUCLEOTIDE; ADENOSINE; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ICATIBANT; INOSINE; PENTOBARBITAL; PURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DEGRADATION; DIALYSATE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; LEFT CORONARY ARTERY; MICRODIALYSIS; NONHUMAN; RABBIT;

ADENINE NUCLEOTIDES; ADENOSINE; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BRADYKININ; HEART; HYPOXANTHINE; INOSINE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RABBITS; RECEPTORS, PURINERGIC P1; THEOPHYLLINE; VASODILATOR AGENTS;

EID: 0030450954     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00788723     Document Type: Article

References (33)

1. Armstrong S, Ganote CE (1994) Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement. Cardiovasc Res 28: 1049-56
2. Borgers M, Thone F (1992) Species differences in adenosine metabolic sites in the heart. Histochem J 24: 445-452
3. Borst MM, Schrader J (1991) Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine. Circ Res 68: 797-806
4. Downey JM, Miura T (1994) The role of adenosine in ischemic preconditioning. In: Hori M, Maruyama Y, Reneman RS (eds) Cardiovascular Adaptation and Failure. Springer-Verlag, Tokyo, pp 147-66
5. Goto M, Liu Y, Yang X-Y, Ardell JL, Cohen MV, Downey JM (1995) Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621
6. Goto M, Cohen MV, Van Wylen GL, Downey JM (1996) Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection. J Mol Cell Cardiol 28: 447-454
7. Itoya M, Miura T, Sakamoto J, Urabe K, Iimura O (1994) Nucleoside transport inhibitors enhances the infarct size-limiting effect of ischemic predonditioning. J Cardiovasc Pharmacol 24: 846-852
8. Jennings RB, Murry CE, Reimer KA (1991) Energy metabolism in preconditioned and control myocardium: Effect of total ischemia. J Mol Cell Cardiol 23: 1449-1458
9. Kida M, Fujiwara H, Ishida M et al. (1991) Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation 84: 2495-2503
10. Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T (1993) Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implication for myocardial salvage. Circulation 87: 208-215
11. Kitakaze M, Hori M, Morioka T et al. (1994) Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation 89: 1237-1246
12. Komamura K, Kitakaze M, Node K (1995) Is activation of 5′-nucleotidase and following adenosine release a common pathway for mediating ischemic preconditioning among species? [Abstract] J Am Coll Cardiol 25 [Abstracts]: 355A
13. Lasly RD, Konyn PJ, Hegge JO, Mentzer Jr RM (1995) Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol 269: H1460-H1466
14. Linz W, Scholkens BA (1987) Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts. J Cardiovasc Pharmacol 10 (Suppl 7): S75-S82
15. 1 receptors in rabbit heart. Circulation 84: 350-356
16. Liu GS, Richard SC, Olsson RA, Mullane K, Walsh RS, Downey JM (1994) Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res 28: 1057-1061
17. Miki T, Miura T, Ogawa T, Ura N, Shimamoto K, Iimura O (1995) Captopril, a kininase II, lowers the threshold of preconditioning through B2 receptor mediated mechanism. [Abstract] Circulation 92 (suppl I): I-455
18. Miura T, Ogawa T, Iwamoto T, Shimamoto K, Iimura O (1992) Dipyriamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation 86: 979-985
19. Miura T, Iimura O (1993) Infarct size limitation by preconditioning: its phenomenological features and the key role of adenosine. Cardiovasc Res 27: 36-42
20. Miura T (1996) Adenosine and bradykinin: Are they independent triggers of preconditioning? Basic Res Cardiol 91: 20-22
21. Murry CE, Richard VJ, Reimer KA, Jennings RB (1990) Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913-931
22. Nees S, Herzog V, Becker BF, Bock M, Des Rosiers C, Gerlach E (1985) The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res Cardiol 80: 515-529
23. Silva PH, Dillon D, Van Wylen DGL (1995) Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. Cardiovasc Res 29: 616-623
24. Schultz R, Rose J, Post H, Heusch G (1995) Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflugers Arch 430: 273-282
25. Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O (1992) Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res 26: 456-461
26. Van der Heide RS, Reimer KA, Jennings RB (1993) Adenosine slows ischemic metabolism in canine myocardium in vitro: relationship to ischaemic preconditioning. Cardiovasc Res 27: 669-673
27. Van Wylen DGL, Willis J, Sodhi J, Weiss RJ, Lasley RD, Mentzer Jr RM (1990) Cardiac microdialysis to measure interstitial adenosine and coronary blood flow. Am J Physiol 259: H1642-H1648
28. Van Wylen DGL (1994) Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 89: 2283-2289
29. Wall TM, Sheehy R, Hartman JC (1994) Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 270: 681-689
30. Wikstrom BG, Ronquist G, Waldenstrom A (1995) Dynamics of myocardial metabolism in the preconditioned porcine heart studied using continuous microdialysis. Eur Heart J 16: 563-569
31. Wirth K, Hock FJ, Albus U et al. (1991) Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol 102: 774-777
32. Yokota R, Fujiwara H, Miyamae M et al. (1995) Transient adenosine infusion before ischemia and reperfusion protects against metabolic damage in pig hearts. Am J Physiol 268: H1149-H1157
33. Zhu P, Zaugg CE, Simper D, Hornstein P, Allegrini PR, Buser PT (1995) Bradykinin improves postischaemic recovery in the rat heart: role of high energy phosphates, nitric oxide, and prostacyclin. Cardiovasc Res 29: 658-663